Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study / Bartolucci, Piero; Brachini, Gioia; Bruzzaniti, Placido; Chiappini, Ambra; Chiarella, Vito; Ciccarone, Fabio; Cicerchia, Pierfranco Maria; Cirillo Bruno De Toma, Giorgio; Di Bartolomeo, Alessandro; Familiari, Pietro; Fiori, Enrico; Fonsi, Giovanni Battista; Franco, Giorgio; Frati, Alessandro; Giugliano, Marco; Iannone, Immacolata; La Torre, Filippo; Lapolla, Pierfrancesco; Leonardo, Costantino; Marruzzo, Giovanni; Meneghini, Simona; Mingoli, Andrea; Prucher, Gian Marco; Ribuffo, Diego; Salvati, Marta; Santoro, Antonio; Sapienza, Paolo; Scafa, Anthony Kevin; Simonelli, Lucilla; Zambon, Martina. - In: BRITISH JOURNAL OF SURGERY. - ISSN 0007-1323. - 108:9(2021), pp. 1056-1063. [10.1093/bjs/znab101]

SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study

BARTOLUCCI Piero;BRACHINI GIOIA;BRUZZANITI PLACIDO;CHIAPPINI AMBRA;CHIARELLA VITO;CICCARONE FABIO;CICERCHIA PIERFRANCO MARIA;DI BARTOLOMEO ALESSANDRO;FAMILIARI PIETRO;FIORI ENRICO;FONSI Giovanni Battista;FRANCO Giorgio;FRATI ALESSANDRO;GIUGLIANO MARCO;IANNONE IMMACOLATA;LA TORRE Filippo;LAPOLLA PIERFRANCESCO;LEONARDO Costantino;MARRUZZO GIOVANNI;MENEGHINI SIMONA;MINGOLI Andrea;PRUCHER GIAN MARCO;RIBUFFO Diego;SALVATI MARTA;SANTORO Antonio;SAPIENZA Paolo;SCAFA ANTHONY KEVIN;SIMONELLI Lucilla;ZAMBON MARTINA
2021

Abstract

Background: Preoperative SARS-CoV-2 vaccination could support safer elective surgery. Vaccine numbers are limited so this study aimed to inform their prioritization by modelling. Methods: The primary outcome was the number needed to vaccinate (NNV) to prevent one COVID-19-related death in 1 year. NNVs were based on postoperative SARS-CoV-2 rates and mortality in an international cohort study (surgical patients), and community SARS-CoV-2 incidence and case fatality data (general population). NNV estimates were stratified by age (18-49, 50-69, 70 or more years) and type of surgery. Best- and worst-case scenarios were used to describe uncertainty. Results: NNVs were more favourable in surgical patients than the general population. The most favourable NNVs were in patients aged 70 years or more needing cancer surgery (351; best case 196, worst case 816) or non-cancer surgery (733; best case 407, worst case 1664). Both exceeded the NNV in the general population (1840; best case 1196, worst case 3066). NNVs for surgical patients remained favourable at a range of SARS-CoV-2 incidence rates in sensitivity analysis modelling. Globally, prioritizing preoperative vaccination of patients needing elective surgery ahead of the general population could prevent an additional 58 687 (best case 115 007, worst case 20 177) COVID-19-related deaths in 1 year. Conclusion: As global roll out of SARS-CoV-2 vaccination proceeds, patients needing elective surgery should be prioritized ahead of the general population.
File allegati a questo prodotto
File Dimensione Formato  
Nepogodiev_SARS-CoV-2_2021.pdf

accesso aperto

Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 239.3 kB
Formato Adobe PDF
239.3 kB Adobe PDF Visualizza/Apri PDF
Nepogodiev_SARS-CoV-2_2021_author_collaborator list.docx

accesso aperto

Tipologia: Altro materiale allegato
Licenza: Tutti i diritti riservati (All rights reserved)
Dimensione 226.25 kB
Formato Microsoft Word XML
226.25 kB Microsoft Word XML Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1602228
Citazioni
  • ???jsp.display-item.citation.pmc??? 211
  • Scopus 30
  • ???jsp.display-item.citation.isi??? 15
social impact